Trainee Spotlight: Munawar Mohammed

Munawar Mohammed's research focuses on developing oral polymeric nanoparticles for sustained drug release.


Munawar Mohammed is a recent MSc graduate in Pharmacy under the supervision of Dr. Ellen Wasan. Prior to joining the college, he received his BPharm and MPharm degrees from Kakatiya University and worked as a lecturer at St. Peter’s Institute of Pharmaceutical Sciences in India. During his time in our College, Munawar Munawar was awarded the New Faculty Graduate Student Scholarship and Graduate Teaching Fellowship. He was also treasurer-secretary of the Student Chapter of the American Association of Pharmaceutical Scientists at the University of Saskatchewan.


For his MPharm, Munawar developed oral self-emulsifying drug delivery systems for agomelatine, an anti-depressant drug. In his MSc research, he focused on developing oral polymeric nanoparticles for sustained drug release of mycophenolate mofetil, an immunosuppressive drug. He also gained experience formulating topical emulsions, developing analytical methods, and conducting in vivo animal studies. Munawar has presented his work at several conferences and is currently working on publishing his results. Moving forward, Munawar wishes to work as a formulation scientist in research and development.


Mohammed, M.; Mansell, H.; Shoker, A.; Wasan, K. M.; Wasan, E. K. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil, Drug Development and Industrial Pharmacy 2018. DOI: 10.1080/03639045.2018.1518455

Mohammed, M.; Syeda, J.; Wasan, K.; Wasan, E. An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery. Pharmaceutics 2017, 9, 53, doi:10.3390/pharmaceutics9040053.

Weekes, D. M.; Cawthray, J. F.; Rieder, M.; Syeda, J.; Ali, M.; Wasan, E.; Kostelnik, T. I.; Patrick, B. O.; Panahifar, A.; Al-Dissi, A.; Cooper, D.; Wasan K. M.; Orvig, C. La(III) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La(dpp)3 and La(XT), and evaluation as treatment for bone resorption disorder. Metallomics 2017, 9, 7, 902-909, doi:10.1039/c7mt00133a.

Share this story